ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,666 | -8.6% | 135,079 | +3.5% | 3.39% | +9.2% |
| Q2 2023 | $4,011 | -22.0% | 130,487 | -8.6% | 3.11% | -18.5% |
| Q1 2023 | $5,143 | +4.9% | 142,748 | +15.0% | 3.81% | -2.8% |
| Q4 2022 | $4,904 | -99.9% | 124,090 | -9.6% | 3.92% | -10.0% |
| Q3 2022 | $5,513,000 | -12.2% | 137,206 | -8.2% | 4.35% | +2.8% |
| Q2 2022 | $6,280,000 | -26.4% | 149,389 | -25.6% | 4.24% | +10.9% |
| Q1 2022 | $8,527,000 | +6.6% | 200,692 | 0.0% | 3.82% | +0.4% |
| Q4 2021 | $7,998,000 | +13.9% | 200,692 | +3.3% | 3.81% | +18.5% |
| Q3 2021 | $7,022,000 | +75.4% | 194,305 | +99.0% | 3.21% | +69.7% |
| Q2 2021 | $4,003,000 | – | 97,656 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |